Pacific Biosciences of California Inc (PACB)
1.55
+0.09
(+6.16%)
USD |
NASDAQ |
Apr 19, 16:00
1.55
0.00 (0.00%)
After-Hours: 20:00
Pacific Biosciences of California Total Assets (Quarterly): 1.746B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.746B |
| September 30, 2023 | 1.898B |
| June 30, 2023 | 1.848B |
| March 31, 2023 | 1.896B |
| December 31, 2022 | 1.767B |
| September 30, 2022 | 1.819B |
| June 30, 2022 | 1.876B |
| March 31, 2022 | 1.937B |
| December 31, 2021 | 2.007B |
| September 30, 2021 | 2.034B |
| June 30, 2021 | 1.246B |
| March 31, 2021 | 1.253B |
| December 31, 2020 | 413.98M |
| September 30, 2020 | 300.32M |
| June 30, 2020 | 213.65M |
| March 31, 2020 | 234.76M |
| December 31, 2019 | 147.98M |
| September 30, 2019 | 146.11M |
| June 30, 2019 | 170.58M |
| March 31, 2019 | 185.58M |
| December 31, 2018 | 170.28M |
| September 30, 2018 | 182.91M |
| June 30, 2018 | 137.06M |
| March 31, 2018 | 156.95M |
| December 31, 2017 | 144.08M |
| Date | Value |
|---|---|
| September 30, 2017 | 157.90M |
| June 30, 2017 | 177.90M |
| March 31, 2017 | 135.51M |
| December 31, 2016 | 137.88M |
| September 30, 2016 | 150.64M |
| June 30, 2016 | 161.37M |
| March 31, 2016 | 140.18M |
| December 31, 2015 | 131.11M |
| September 30, 2015 | 99.78M |
| June 30, 2015 | 96.77M |
| March 31, 2015 | 106.42M |
| December 31, 2014 | 124.39M |
| September 30, 2014 | 121.64M |
| June 30, 2014 | 128.24M |
| March 31, 2014 | 141.04M |
| December 31, 2013 | 136.18M |
| September 30, 2013 | 152.80M |
| June 30, 2013 | 134.28M |
| March 31, 2013 | 139.77M |
| December 31, 2012 | 129.68M |
| September 30, 2012 | 148.21M |
| June 30, 2012 | 169.93M |
| March 31, 2012 | 194.74M |
| December 31, 2011 | 218.32M |
| September 30, 2011 | 237.96M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
146.11M
Minimum
Sep 2019
2.034B
Maximum
Sep 2021
1.208B
Average
1.746B
Median
Dec 2023
Total Assets (Quarterly) Benchmarks
| Cerus Corp | 197.75M |
| Axogen Inc | 196.83M |
| AVITA Medical Inc | 111.64M |
| BioSig Technologies Inc | 1.798M |
| Intellia Therapeutics Inc | 1.301B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.045B |
| Shareholders Equity (Quarterly) | 701.30M |
| Debt to Equity Ratio | 1.273 |
| Current Ratio | 7.809 |
| Net Debt Paydown Yield | 0.03% |